Iproteos

Iproteos

Iproteos is an award-winning biotechnology company, spun out of the Institute for Research in Biomedicine/University of Barcelona. It specialises in the development of third-generation drugs based on peptidomimetics, molecules able to modulate the activity of undruggable targets, such as Protein-Protein Interactions (PPIs). Several drugs with proven efficacy for treating cognitive impairment associated with schizophrenia are in the preclinical phase. The company closed its C round, lead by Caixa Capital RISC, in October 2016.

visit website

Skills

Posted on

17/11/2019